Nuvo Reseach NRI.to FDA decision Pliaglis

FDA decision on Pliaglis are reporter today because they don't have any information on the product. It's not a bad news same if the stock price have down today. This news just want say that the answer of the FDA will be reported. Nuvo research should,against me, give the reason on their web site because the investor don't no what will be appened. As soon as the FDA will receive all the information, FDA will give the decision if Pliaglis will be approuved. More detail to come.

Good day for american market, TSX and TSX-V are neutral

During the afternoon, the markets have stabilized and limit their downward trends.The situation of U.S. markets is better off facing the TSX and TSX-V. Any sector of the TSX is doing better, as the finance sector, the telecommunications sectorwhich peaked in recent months, the consumer goods sector which peaked the last 6 months. Since March this sector is strong enough. Maybe he should wear an eyeon it to follow the next direction. The health sector remains quite strong too. The decline in the TSX over the last week is part of a lower energy and resources.These sectors have stabilized but remains bullish.

NRI.to FDA decision

Against all odds, yesterday was the date that many of us expected, the date that the FDA makes are Pliaglis verdict on the product. The company Nuvo Researchannounced that the datede césision was April 16, 2012 but no news came out.Does he need fear nothing appeared in the news, I think not. I think the decision will be revealed shortly. The company has no interest in hiding the FDA decision.However, this can be frustrating is that the company announced that the date wasApril 16 and several people looked impacience decision. The company could haveéemttre a statement saying the decision would be made soon instead of waiting for people who awaited the decision.

MaxiMarketTrading Blog and Forum: Potash corp of saskatchewan - Pot.to

MaxiMarketTrading Blog and Forum: Potash corp of saskatchewan - Pot.to: The share price of Potash Corp of Saskatchewan has declined in recent days . The title usually follows the market and as lew ...

Potash corp of saskatchewan - Pot.to

The share price of Potash Corp of Saskatchewan has declined in recent days. The title usually follows the market and as lew bear market, it is normal to see Dessendre. In the graph of Friday, April 13, 2012, we remarqu'ons that the next resistance is around $ 42 and the second in the $ 39 resistance. However, trading volumes are low during the last week versus the previous month. The RSI is recovering around 40 indicates that the title is a bit oversold but not important. If the RSI was to descend into the 20, we would have a good oportunity to buy in my opinion because it's not a bad companie, it is profitable and well managed. Demand for its product is still await you. I think the reason for the decline in recent days is the market trend.